MEDI-7219
- Generic Name
- MEDI-7219
A 6-Part Study In Healthy Volunteers To Evaluate Safety, Tolerability and Uptake Of MEDI7219 in the Body When Given as Single and Multiple Doses
Phase 1
Terminated
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2017-12-05
- Last Posted Date
- 2020-08-31
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 186
- Registration Number
- NCT03362593
- Locations
- 🇬🇧
Research Site, Ruddington, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath